Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Pharmacology›Anesthetics
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Anesthetics

Pharmacology · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed9 referencesApproximately 4 min read

Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 3 complete abstracts (698 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general anesthesia, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Anesthetic; Anesthetic Agents; Agents, Anesthetic; Anesthetic Drugs; Drugs, Anesthetic; Anesthetic Effect; Effect, Anesthetic; Anesthetic Effects.

Where it fits in the MeSH classification

Broader topics
Central Nervous System Depressants
Narrower topics
Anesthetics, Combined; Anesthetics, General; Anesthetics, Local
See also
Analgesics; Anesthesia; Adjuvants, Anesthesia

Related concepts

  • Anesthesia

Research landscape

PubMed indexes 93,083 records tagged with the MeSH heading “Anesthetics” (counts retrieved 2026-10-29). 13,334 of them (14.3%) were published from 2020 onward, and the busiest period so far is through 1999 with 31,849 records.

Reviews account for 10,065 records (10.8%) and meta-analyses for 1,167. Randomized controlled trials number 16,357 (17.6%) as a share of all records on the topic. Randomized trials make up a comparatively large share of this literature, which means many treatment questions have been tested directly.

PubMed records by publication periodthrough 1999: 31,849 records; 2000-2009: 23,830 records; 2010-2019: 24,070 records; 2020 onward: 13,334 records31,849through 199923,8302000-200924,0702010-201913,3342020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199931,849
2000-200923,830
2010-201924,070
2020 onward13,334
Share of records by publication typeReviews: 10.8 percent; Meta-analyses: 1.3 percent; Randomized controlled trials: 17.6 percentReviews10.8% (10,065)Meta-analyses1.3% (1,167)Randomized controlled trials17.6% (16,357)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 93,083 PubMed records
TypeRecordsShare
Reviews10,06510.8%
Meta-analyses1,1671.3%
Randomized controlled trials16,35717.6%

Method: PubMed query "Anesthetics"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in pharmacology

Drug evidence builds in layers: laboratory pharmacology describes how a compound acts, pharmacokinetic studies describe how the body handles it, and randomized trials test whether it helps and what harms it causes. Post-marketing surveillance and observational studies reveal rarer adverse effects but cannot prove causation. This page is educational and is not a recommendation to start, stop or change any medicine; decisions about treatment belong with a qualified clinician.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Comparison of opioid-free versus opioid-based total intravenous anaesthesia in elderly patients undergoing short-duration surgery: a randomized controlled trial
Wei S, Zhou S, Tu J, Zhi T, Wang Y, Shen Q, et al.
2026Randomized controlled trial
Design not recorded in structured metadata
7cc by
PMID 41656873 · DOI · PMC12888356
General anesthesia and depth of anesthesia (DoA) evaluation methods in laboratory animals: a comprehensive review
Altınoluk T, Kazdağlı H
2026Review article
Design not recorded in structured metadata
5cc by
PMID 41843253 · DOI · PMC12995938
Targeting Ferroptosis Pathways for Synaptic Protection in Sevoflurane-Induced Cognitive Impairment: A Nanomedicine Approach
Zhao B, Wang C, Zhang M
2026Review article
Design not recorded in structured metadata
3cc by
PMID 41917795 · DOI · PMC13140902

Comparison of opioid-free versus opioid-based total intravenous anaesthesia in elderly patients undergoing short-duration surgery: a randomized controlled trial [1]

Randomized controlled trial Wei S, Zhou S, Tu J, Zhi T, Wang Y, Shen Q, et al. · · 2026 · cited 7 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
IntroductionOlder adults who undergo short-duration surgery are vulnerable to opioid-related complications.
Closing excerpt
Trial registrationChinese Clinical Trial Registry, ChiCTR2500102550.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (210 words)

IntroductionOlder adults who undergo short-duration surgery are vulnerable to opioid-related complications. It is uncertain whether an opioid-free total intravenous anaesthesia (OFA) can reduce these events. We aimed to determine whether OFA reduces the incidence of major postoperative adverse events compared with standard opioid-based total intravenous anaesthesia (OBA).Patients and methodsThis single-center randomized clinical trial was conducted in China. From May to August 2025, 400 patients aged ≥60 years undergoing elective, short-duration surgery (anticipated duration of less than 90 min) were randomized 1:1 to receive either OFA (n = 200) or OBA (n = 200). The primary outcome was a composite of postoperative hypoxemia, delirium, or nausea and vomiting (PONV) within 48 h.ResultsA total of 400 randomized patients (mean [SD] age, 69.5 [7.0] years; 125 [31.3%] women). The primary composite outcome occurred in 50 patients (25.0%) in the OFA group and 87 patients (43.5%) in the OBA group (adjusted odds ratio, 0.40; 95% CI, 0.25 to 0.62; p p = .005) and longer extubation times (mean, 9.5 vs 7.2 min; p ConclusionThese findings suggest that OFA is a viable alternative to opioid-based anesthesia for improving postoperative outcomes by reducing the incidence of hypoxemia and PONV in this population, while warranting careful management of its associated side effects.Trial registrationChinese Clinical Trial Registry, ChiCTR2500102550.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41656873 · DOI · PMC12888356

General anesthesia and depth of anesthesia (DoA) evaluation methods in laboratory animals: a comprehensive review [2]

Review article Altınoluk T, Kazdağlı H · · 2026 · cited 5 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
In preclinical research, general anesthesia is essential for humane and feasible procedures but profoundly modulates autonomic, cardiovascular, neurological, and biochemical systems, risking bias in experimental outcomes.
Closing excerpt
These strategies will improve animal welfare and enhance the reproducibility and interpretability of preclinical findings.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (232 words)

In preclinical research, general anesthesia is essential for humane and feasible procedures but profoundly modulates autonomic, cardiovascular, neurological, and biochemical systems, risking bias in experimental outcomes. In this review our aim was to synthesize current knowledge on commonly used general anesthetics in laboratory animals, their mechanisms and protocols across species (mice, rats, rabbits, pigs), and evidence-based methods to evaluate depth of anesthesia (DoA). Injectable agents (ketamine with α2-agonists, barbiturates, propofol) and inhalational agents (isoflurane, sevoflurane, desflurane) act primarily via NMDA antagonism or GABA-A/glycine modulation, with distinct profiles for analgesia, hemodynamics, respiration, and recovery. Species-specific dosing and routes are summarized for small rodents, rabbits, and pigs, including practical considerations (e.g., thermoregulation, airway management, malignant hyperthermia risk). DoA assessment spans traditional reflex-based scoring and advanced monitoring. EEG, raw and processed indices (e.g., BIS), offers continuous cortical information but requires species-specific validation and cautious interpretation. Autonomic indicators (heart rate, blood pressure, respiratory patterns) and heart-rate variability provide complementary, noninvasive signals yet are confounded by drugs, ventilation, and surgical stimuli. Anesthetic choice is a major experimental variable. Reliable practice demands multimodal DoA monitoring that integrates reflexes, physiologic trends, and, where feasible, EEG, alongside rigorous, species-adapted protocols and transparent reporting. Priorities include validated EEG algorithms for nonhuman species, standardized autonomic indices, and broader adoption of awake models when compatible with scientific aims. These strategies will improve animal welfare and enhance the reproducibility and interpretability of preclinical findings.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41843253 · DOI · PMC12995938

Targeting Ferroptosis Pathways for Synaptic Protection in Sevoflurane-Induced Cognitive Impairment: A Nanomedicine Approach [3]

Review article Zhao B, Wang C, Zhang M · · 2026 · cited 3 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundPostoperative cognitive dysfunction (POCD) is an increasingly recognized neurological complication following surgery, particularly in elderly patients.
Closing excerpt
Further research is needed to optimize these therapeutic approaches for clinical application in POCD management.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (256 words)

BackgroundPostoperative cognitive dysfunction (POCD) is an increasingly recognized neurological complication following surgery, particularly in elderly patients. It significantly hinders recovery and impairs the quality of life. Sevoflurane, a commonly used volatile anesthetic, has been implicated in enhancing the incidence and severity of POCD. At the molecular level, synaptic dysfunction is a major contributor to cognitive decline associated with POCD. Recent studies have highlighted ferroptosis, an iron-dependent form of cell death driven by lipid peroxidation, as a critical mechanism behind synaptic damage and cognitive decline.MethodsThis review synthesizes current research on the role of ferroptosis in POCD, focusing on its impact on synaptic dysfunction. We also explore the potential of nanomedicine, particularly intelligent responsive nanodrug delivery systems, in targeting ferroptotic pathways. These nanoplatforms, with their high brain delivery efficiency and specificity, have been shown to modulate ferroptosis signaling and reduce neuronal injury, thereby potentially promoting cognitive recovery.ResultsFerroptosis plays a significant role in exacerbating cognitive deficits by disrupting synaptic membranes and mitochondria, which contribute to synaptic dysfunction. Emerging evidence suggests that interventions targeting ferroptosis pathways can mitigate these effects, offering a novel therapeutic avenue for POCD. Nanomedicine approaches, especially those utilizing responsive nanodrug delivery systems, have shown promise in effectively targeting ferroptotic pathways with high specificity, leading to reductions in synaptic injury and enhanced cognitive recovery.ConclusionFerroptosis is a key mechanism driving synaptic dysfunction and cognitive decline in POCD. Targeting ferroptotic pathways using nanomedicine-based strategies holds considerable promise for mitigating POCD and promoting cognitive recovery. Further research is needed to optimize these therapeutic approaches for clinical application in POCD management.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41917795 · DOI · PMC13140902

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults [4]
    Weibel S, Jelting Y, Pace NL, Helf A, Eberhart LH, Hahnenkamp K, et al. · Cochrane Database Syst Rev · 2018 · cited 203 times (Europe PMC)
  • Research article Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery [5]
    Miller D, Lewis SR, Pritchard MW, Schofield-Robinson OJ, Shelton CL, Alderson P, et al. · Cochrane Database Syst Rev · 2018 · cited 180 times (Europe PMC)
  • Research article The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders [6]
    Kokkinou M, Ashok AH, Howes OD · Mol Psychiatry · 2018 · cited 180 times (Europe PMC)
  • Research article Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia [7]
    Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B, Global Onco-Anesthesia Research Collaboration Group · Can J Anaesth · 2019 · cited 154 times (Europe PMC)
  • Research article Pharmacotherapy for the Prevention of Chronic Pain after Surgery in Adults: An Updated Systematic Review and Meta-analysis [8]
    Carley ME, Chaparro LE, Choinière M, Kehlet H, Moore RA, Van Den Kerkhof E, et al. · Anesthesiology · 2021 · cited 114 times (Europe PMC)
  • Research article Anesthetic Exposure During Childhood and Neurodevelopmental Outcomes: A Systematic Review and Meta-analysis [9]
    Reighard C, Junaid S, Jackson WM, Arif A, Waddington H, Whitehouse AJO, et al. · JAMA Netw Open · 2022 · cited 86 times (Europe PMC)

References

  1. Wei S, Zhou S, Tu J, Zhi T, Wang Y, Shen Q, et al.. Comparison of opioid-free versus opioid-based total intravenous anaesthesia in elderly patients undergoing short-duration surgery: a randomized controlled trial. . 2026. PMID 41656873 · DOI · PMC12888356
  2. Altınoluk T, Kazdağlı H. General anesthesia and depth of anesthesia (DoA) evaluation methods in laboratory animals: a comprehensive review. . 2026. PMID 41843253 · DOI · PMC12995938
  3. Zhao B, Wang C, Zhang M. Targeting Ferroptosis Pathways for Synaptic Protection in Sevoflurane-Induced Cognitive Impairment: A Nanomedicine Approach. . 2026. PMID 41917795 · DOI · PMC13140902
  4. Weibel S, Jelting Y, Pace NL, Helf A, Eberhart LH, Hahnenkamp K, et al.. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults. Cochrane Database Syst Rev. 2018. PMID 29864216 · DOI · PMC6513586
  5. Miller D, Lewis SR, Pritchard MW, Schofield-Robinson OJ, Shelton CL, Alderson P, et al.. Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2018. PMID 30129968 · DOI · PMC6513211
  6. Kokkinou M, Ashok AH, Howes OD. The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders. Mol Psychiatry. 2018. PMID 28972576 · DOI · PMC5754467
  7. Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B, Global Onco-Anesthesia Research Collaboration Group. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth. 2019. PMID 30834506 · DOI
  8. Carley ME, Chaparro LE, Choinière M, Kehlet H, Moore RA, Van Den Kerkhof E, et al.. Pharmacotherapy for the Prevention of Chronic Pain after Surgery in Adults: An Updated Systematic Review and Meta-analysis. Anesthesiology. 2021. PMID 34237128 · DOI
  9. Reighard C, Junaid S, Jackson WM, Arif A, Waddington H, Whitehouse AJO, et al.. Anesthetic Exposure During Childhood and Neurodevelopmental Outcomes: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022. PMID 35708687 · DOI · PMC9204549

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Neuroprotective AgentsPharmacology
  • HallucinogensPharmacology
  • NarcoticsPharmacology
  • Calcium Channel BlockersPharmacology
  • Antipsychotic AgentsPharmacology
  • Cyclooxygenase InhibitorsPharmacology

All 99 articles in Pharmacology →

At a glance

93,083
PubMed records on this heading
14%
published since 2020
10,065
review articles
16,357
randomized trials
9
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Neuroprotective AgentsPharmacology
  • HallucinogensPharmacology
  • NarcoticsPharmacology
  • Calcium Channel BlockersPharmacology
  • Antipsychotic AgentsPharmacology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support